Table 1 |
|||
| HaCaT experimental design | |||
| Over-expression | Media | Treatment | Replicates |
| none | serum | none | 3 |
| vector | serum | none | 3 |
| vector | none | none | 4 |
| vector | EGF | none | 4 |
| vector | TNF | none | 3 |
| HRASVal12D | serum | none | 3 |
| p65WT | serum | none | 3 |
| p65WT | none | none | 3 |
| p65WT | TNF | none | 5 |
| EGFRWT | serum | none | 5 |
| EGFRWT | none | none | 7 |
| EGFRWT | EGF | none | 7 |
Summary of the experimental conditions in the HaCaT cell line expression experiments, provided in further detail in Supplemental File 5.
Fertig et al. BMC Genomics 2012 13:160 doi:10.1186/1471-2164-13-160
